Cite
HARVARD Citation
Cohen, M. et al. (n.d.). The "Dual‐Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2‐TIMI 51 Trial. Cardiovascular therapeutics. 32 (5), pp. 224-232. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cohen, M. et al. (n.d.). The "Dual‐Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2‐TIMI 51 Trial. Cardiovascular therapeutics. 32 (5), pp. 224-232. [Online].